Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment of Valvular Heart Disease During Pregnancy for Improving Maternal and Neonatal Outcome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434301/all/Carnitine_supplementation_for_inborn_errors_of_metabolism_Edited__no_change_to_conclusions_. Accessed 06 June 2023.
Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434301/all/Carnitine_supplementation_for_inborn_errors_of_metabolism_Edited__no_change_to_conclusions_. Accessed June 6, 2023.
Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434301/all/Carnitine_supplementation_for_inborn_errors_of_metabolism_Edited__no_change_to_conclusions_
Treatment of Valvular Heart Disease During Pregnancy for Improving Maternal and Neonatal Outcome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 June 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434301/all/Carnitine_supplementation_for_inborn_errors_of_metabolism_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome: Cochrane systematic review
ID - 434301
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434301/all/Carnitine_supplementation_for_inborn_errors_of_metabolism_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -